Bridging the immunogenicity of a tetravalent dengue vaccine (TAK-003) from children and adolescents to adults

Immunobridging is an important methodology that can be used to extrapolate vaccine efficacy estimates to populations not evaluated in clinical studies, and that has been successfully used in developing many vaccines. Dengue, caused by a mosquito-transmitted flavivirus endemic to many tropical and su...

Descripción completa

Detalles Bibliográficos
Autores principales: LeFevre, Inge, Bravo, Lulu, Folschweiller, Nicolas, Medina, Eduardo Lopez, Moreira, Edson Duarte, Nordio, Francesco, Sharma, Mayuri, Tharenos, Leslie M., Tricou, Vianney, Watanaveeradej, Veerachai, Winkle, Peter J., Biswal, Shibadas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208910/
https://www.ncbi.nlm.nih.gov/pubmed/37230978
http://dx.doi.org/10.1038/s41541-023-00670-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208910/
https://www.ncbi.nlm.nih.gov/pubmed/37230978
http://dx.doi.org/10.1038/s41541-023-00670-6

Ejemplares similares